img

Global Somatuline Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Somatuline Drugs Market Insights, Forecast to 2034

Somatuline is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
Global Somatuline Drugs market is expected to reach to US$ 1415 million in 2024, with a positive growth of %, compared with US$ 1401 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Somatuline Drugs industry is evaluated to reach US$ 1506.5 million in 2029. The CAGR will be 1.1% during 2024 to 2029.
Lanreotide is a somatostatin analog primarily used to treat acromegaly and neuroendocrine tumors. Its efficacy in controlling hormone secretion and tumor growth has driven market growth. The rising prevalence of acromegaly and neuroendocrine tumors, coupled with the drug's extended duration of action, contributes to its popularity. However, competition from other somatostatin analogs and the need for individualized treatment plans may pose challenges. The market is relatively small compared to other therapeutic areas. Despite challenges, the Lanreotide market presents potential for expansion as healthcare providers prioritize personalized and targeted therapies for acromegaly and neuroendocrine tumors, creating opportunities for further development and investment.
Report Covers
This report presents an overview of global Somatuline Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Somatuline Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


IPSEN
Segment by Type
60 mg
90 mg
120 mg

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Somatuline Drugs plant distribution, commercial date of Somatuline Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Somatuline Drugs introduction, etc. Somatuline Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Somatuline Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Somatuline Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Somatuline Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 60 mg
1.2.3 90 mg
1.2.4 120 mg
1.3 Market by Application
1.3.1 Global Somatuline Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Somatuline Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Somatuline Drugs Revenue by Region
2.2.1 Global Somatuline Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Somatuline Drugs Revenue by Region (2018-2024)
2.2.3 Global Somatuline Drugs Revenue by Region (2024-2029)
2.2.4 Global Somatuline Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Somatuline Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Somatuline Drugs Sales by Region
2.4.1 Global Somatuline Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Somatuline Drugs Sales by Region (2018-2024)
2.4.3 Global Somatuline Drugs Sales by Region (2024-2029)
2.4.4 Global Somatuline Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Somatuline Drugs Sales by Manufacturers
3.1.1 Global Somatuline Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Somatuline Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Somatuline Drugs in 2022
3.2 Global Somatuline Drugs Revenue by Manufacturers
3.2.1 Global Somatuline Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Somatuline Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Somatuline Drugs Revenue in 2022
3.3 Global Key Players of Somatuline Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Somatuline Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Somatuline Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Somatuline Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Somatuline Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Somatuline Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Somatuline Drugs Sales by Type
4.1.1 Global Somatuline Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Somatuline Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Somatuline Drugs Sales Market Share by Type (2018-2029)
4.2 Global Somatuline Drugs Revenue by Type
4.2.1 Global Somatuline Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Somatuline Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Somatuline Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Somatuline Drugs Price by Type
4.3.1 Global Somatuline Drugs Price by Type (2018-2024)
4.3.2 Global Somatuline Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Somatuline Drugs Sales by Application
5.1.1 Global Somatuline Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Somatuline Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Somatuline Drugs Sales Market Share by Application (2018-2029)
5.2 Global Somatuline Drugs Revenue by Application
5.2.1 Global Somatuline Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Somatuline Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Somatuline Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Somatuline Drugs Price by Application
5.3.1 Global Somatuline Drugs Price by Application (2018-2024)
5.3.2 Global Somatuline Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Somatuline Drugs Market Size by Type
6.1.1 US & Canada Somatuline Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Somatuline Drugs Revenue by Type (2018-2029)
6.2 US & Canada Somatuline Drugs Market Size by Application
6.2.1 US & Canada Somatuline Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Somatuline Drugs Revenue by Application (2018-2029)
6.3 US & Canada Somatuline Drugs Market Size by Country
6.3.1 US & Canada Somatuline Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Somatuline Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Somatuline Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Somatuline Drugs Market Size by Type
7.1.1 Europe Somatuline Drugs Sales by Type (2018-2029)
7.1.2 Europe Somatuline Drugs Revenue by Type (2018-2029)
7.2 Europe Somatuline Drugs Market Size by Application
7.2.1 Europe Somatuline Drugs Sales by Application (2018-2029)
7.2.2 Europe Somatuline Drugs Revenue by Application (2018-2029)
7.3 Europe Somatuline Drugs Market Size by Country
7.3.1 Europe Somatuline Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Somatuline Drugs Sales by Country (2018-2029)
7.3.3 Europe Somatuline Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Somatuline Drugs Market Size
8.1.1 China Somatuline Drugs Sales (2018-2029)
8.1.2 China Somatuline Drugs Revenue (2018-2029)
8.2 China Somatuline Drugs Market Size by Application
8.2.1 China Somatuline Drugs Sales by Application (2018-2029)
8.2.2 China Somatuline Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Somatuline Drugs Market Size by Type
9.1.1 Asia Somatuline Drugs Sales by Type (2018-2029)
9.1.2 Asia Somatuline Drugs Revenue by Type (2018-2029)
9.2 Asia Somatuline Drugs Market Size by Application
9.2.1 Asia Somatuline Drugs Sales by Application (2018-2029)
9.2.2 Asia Somatuline Drugs Revenue by Application (2018-2029)
9.3 Asia Somatuline Drugs Sales by Region
9.3.1 Asia Somatuline Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Somatuline Drugs Revenue by Region (2018-2029)
9.3.3 Asia Somatuline Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Somatuline Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Somatuline Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Somatuline Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Somatuline Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Somatuline Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Somatuline Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Somatuline Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Somatuline Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Somatuline Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Somatuline Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 IPSEN
11.1.1 IPSEN Company Information
11.1.2 IPSEN Overview
11.1.3 IPSEN Somatuline Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 IPSEN Somatuline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 IPSEN Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Somatuline Drugs Industry Chain Analysis
12.2 Somatuline Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Somatuline Drugs Production Mode & Process
12.4 Somatuline Drugs Sales and Marketing
12.4.1 Somatuline Drugs Sales Channels
12.4.2 Somatuline Drugs Distributors
12.5 Somatuline Drugs Customers
13 Market Dynamics
13.1 Somatuline Drugs Industry Trends
13.2 Somatuline Drugs Market Drivers
13.3 Somatuline Drugs Market Challenges
13.4 Somatuline Drugs Market Restraints
14 Key Findings in The Global Somatuline Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Somatuline Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 60 mg
Table 3. Major Manufacturers of 90 mg
Table 4. Major Manufacturers of 120 mg
Table 5. Global Somatuline Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Somatuline Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Somatuline Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Somatuline Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Somatuline Drugs Revenue Market Share by Region (2018-2024)
Table 10. Global Somatuline Drugs Revenue Market Share by Region (2024-2029)
Table 11. Global Somatuline Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Somatuline Drugs Sales by Region (2018-2024) & (Units)
Table 13. Global Somatuline Drugs Sales by Region (2024-2029) & (Units)
Table 14. Global Somatuline Drugs Sales Market Share by Region (2018-2024)
Table 15. Global Somatuline Drugs Sales Market Share by Region (2024-2029)
Table 16. Global Somatuline Drugs Sales by Manufacturers (2018-2024) & (Units)
Table 17. Global Somatuline Drugs Sales Share by Manufacturers (2018-2024)
Table 18. Global Somatuline Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Somatuline Drugs Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Somatuline Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Somatuline Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 22. Global Somatuline Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Somatuline Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Somatuline Drugs as of 2022)
Table 24. Global Key Manufacturers of Somatuline Drugs, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Somatuline Drugs, Product Offered and Application
Table 26. Global Key Manufacturers of Somatuline Drugs, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Somatuline Drugs Sales by Type (2018-2024) & (Units)
Table 29. Global Somatuline Drugs Sales by Type (2024-2029) & (Units)
Table 30. Global Somatuline Drugs Sales Share by Type (2018-2024)
Table 31. Global Somatuline Drugs Sales Share by Type (2024-2029)
Table 32. Global Somatuline Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Somatuline Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Somatuline Drugs Revenue Share by Type (2018-2024)
Table 35. Global Somatuline Drugs Revenue Share by Type (2024-2029)
Table 36. Somatuline Drugs Price by Type (2018-2024) & (USD/Unit)
Table 37. Global Somatuline Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Somatuline Drugs Sales by Application (2018-2024) & (Units)
Table 39. Global Somatuline Drugs Sales by Application (2024-2029) & (Units)
Table 40. Global Somatuline Drugs Sales Share by Application (2018-2024)
Table 41. Global Somatuline Drugs Sales Share by Application (2024-2029)
Table 42. Global Somatuline Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Somatuline Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Somatuline Drugs Revenue Share by Application (2018-2024)
Table 45. Global Somatuline Drugs Revenue Share by Application (2024-2029)
Table 46. Somatuline Drugs Price by Application (2018-2024) & (USD/Unit)
Table 47. Global Somatuline Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Somatuline Drugs Sales by Type (2018-2024) & (Units)
Table 49. US & Canada Somatuline Drugs Sales by Type (2024-2029) & (Units)
Table 50. US & Canada Somatuline Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Somatuline Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Somatuline Drugs Sales by Application (2018-2024) & (Units)
Table 53. US & Canada Somatuline Drugs Sales by Application (2024-2029) & (Units)
Table 54. US & Canada Somatuline Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Somatuline Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Somatuline Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Somatuline Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Somatuline Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Somatuline Drugs Sales by Country (2018-2024) & (Units)
Table 60. US & Canada Somatuline Drugs Sales by Country (2024-2029) & (Units)
Table 61. Europe Somatuline Drugs Sales by Type (2018-2024) & (Units)
Table 62. Europe Somatuline Drugs Sales by Type (2024-2029) & (Units)
Table 63. Europe Somatuline Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Somatuline Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Somatuline Drugs Sales by Application (2018-2024) & (Units)
Table 66. Europe Somatuline Drugs Sales by Application (2024-2029) & (Units)
Table 67. Europe Somatuline Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Somatuline Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Somatuline Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Somatuline Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Somatuline Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Somatuline Drugs Sales by Country (2018-2024) & (Units)
Table 73. Europe Somatuline Drugs Sales by Country (2024-2029) & (Units)
Table 74. China Somatuline Drugs Sales by Type (2018-2024) & (Units)
Table 75. China Somatuline Drugs Sales by Type (2024-2029) & (Units)
Table 76. China Somatuline Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Somatuline Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Somatuline Drugs Sales by Application (2018-2024) & (Units)
Table 79. China Somatuline Drugs Sales by Application (2024-2029) & (Units)
Table 80. China Somatuline Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Somatuline Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Somatuline Drugs Sales by Type (2018-2024) & (Units)
Table 83. Asia Somatuline Drugs Sales by Type (2024-2029) & (Units)
Table 84. Asia Somatuline Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Somatuline Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Somatuline Drugs Sales by Application (2018-2024) & (Units)
Table 87. Asia Somatuline Drugs Sales by Application (2024-2029) & (Units)
Table 88. Asia Somatuline Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Somatuline Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Somatuline Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Somatuline Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Somatuline Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Somatuline Drugs Sales by Region (2018-2024) & (Units)
Table 94. Asia Somatuline Drugs Sales by Region (2024-2029) & (Units)
Table 95. Middle East, Africa and Latin America Somatuline Drugs Sales by Type (2018-2024) & (Units)
Table 96. Middle East, Africa and Latin America Somatuline Drugs Sales by Type (2024-2029) & (Units)
Table 97. Middle East, Africa and Latin America Somatuline Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Somatuline Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Somatuline Drugs Sales by Application (2018-2024) & (Units)
Table 100. Middle East, Africa and Latin America Somatuline Drugs Sales by Application (2024-2029) & (Units)
Table 101. Middle East, Africa and Latin America Somatuline Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Somatuline Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Somatuline Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Somatuline Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Somatuline Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Somatuline Drugs Sales by Country (2018-2024) & (Units)
Table 107. Middle East, Africa and Latin America Somatuline Drugs Sales by Country (2024-2029) & (Units)
Table 108. IPSEN Company Information
Table 109. IPSEN Description and Major Businesses
Table 110. IPSEN Somatuline Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. IPSEN Somatuline Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. IPSEN Recent Developments
Table 113. Key Raw Materials Lists
Table 114. Raw Materials Key Suppliers Lists
Table 115. Somatuline Drugs Distributors List
Table 116. Somatuline Drugs Customers List
Table 117. Somatuline Drugs Market Trends
Table 118. Somatuline Drugs Market Drivers
Table 119. Somatuline Drugs Market Challenges
Table 120. Somatuline Drugs Market Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Somatuline Drugs Product Picture
Figure 2. Global Somatuline Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Somatuline Drugs Market Share by Type in 2022 & 2029
Figure 4. 60 mg Product Picture
Figure 5. 90 mg Product Picture
Figure 6. 120 mg Product Picture
Figure 7. Global Somatuline Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Somatuline Drugs Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Pharmacy
Figure 11. Somatuline Drugs Report Years Considered
Figure 12. Global Somatuline Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Somatuline Drugs Revenue 2018-2029 (US$ Million)
Figure 14. Global Somatuline Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Somatuline Drugs Revenue Market Share by Region (2018-2029)
Figure 16. Global Somatuline Drugs Sales 2018-2029 ((Units)
Figure 17. Global Somatuline Drugs Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Somatuline Drugs Sales YoY (2018-2029) & (Units)
Figure 19. US & Canada Somatuline Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Somatuline Drugs Sales YoY (2018-2029) & (Units)
Figure 21. Europe Somatuline Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Somatuline Drugs Sales YoY (2018-2029) & (Units)
Figure 23. China Somatuline Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Somatuline Drugs Sales YoY (2018-2029) & (Units)
Figure 25. Asia (excluding China) Somatuline Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Somatuline Drugs Sales YoY (2018-2029) & (Units)
Figure 27. Middle East, Africa and Latin America Somatuline Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Somatuline Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Somatuline Drugs in the World: Market Share by Somatuline Drugs Revenue in 2022
Figure 30. Global Somatuline Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Somatuline Drugs Sales Market Share by Type (2018-2029)
Figure 32. Global Somatuline Drugs Revenue Market Share by Type (2018-2029)
Figure 33. Global Somatuline Drugs Sales Market Share by Application (2018-2029)
Figure 34. Global Somatuline Drugs Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Somatuline Drugs Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Somatuline Drugs Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Somatuline Drugs Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Somatuline Drugs Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Somatuline Drugs Revenue Share by Country (2018-2029)
Figure 40. US & Canada Somatuline Drugs Sales Share by Country (2018-2029)
Figure 41. U.S. Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Somatuline Drugs Sales Market Share by Type (2018-2029)
Figure 44. Europe Somatuline Drugs Revenue Market Share by Type (2018-2029)
Figure 45. Europe Somatuline Drugs Sales Market Share by Application (2018-2029)
Figure 46. Europe Somatuline Drugs Revenue Market Share by Application (2018-2029)
Figure 47. Europe Somatuline Drugs Revenue Share by Country (2018-2029)
Figure 48. Europe Somatuline Drugs Sales Share by Country (2018-2029)
Figure 49. Germany Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 50. France Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 51. UK Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. China Somatuline Drugs Sales Market Share by Type (2018-2029)
Figure 55. China Somatuline Drugs Revenue Market Share by Type (2018-2029)
Figure 56. China Somatuline Drugs Sales Market Share by Application (2018-2029)
Figure 57. China Somatuline Drugs Revenue Market Share by Application (2018-2029)
Figure 58. Asia Somatuline Drugs Sales Market Share by Type (2018-2029)
Figure 59. Asia Somatuline Drugs Revenue Market Share by Type (2018-2029)
Figure 60. Asia Somatuline Drugs Sales Market Share by Application (2018-2029)
Figure 61. Asia Somatuline Drugs Revenue Market Share by Application (2018-2029)
Figure 62. Asia Somatuline Drugs Revenue Share by Region (2018-2029)
Figure 63. Asia Somatuline Drugs Sales Share by Region (2018-2029)
Figure 64. Japan Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. India Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Somatuline Drugs Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Somatuline Drugs Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Somatuline Drugs Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Somatuline Drugs Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Somatuline Drugs Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Somatuline Drugs Sales Share by Country (2018-2029)
Figure 75. Brazil Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Somatuline Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Somatuline Drugs Value Chain
Figure 81. Somatuline Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed